Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.

A pharmaceutical corporation sued Colorado Friday in federal court aiming to bring a halt to a law approved in 2023, which the New Jersey-based company said makes it provide generic allergy pens to ...

A new mold concept developed by Zahoransky is engineered to accelerate the mass production of housings for insulin pens and auto injectors in a space- and energy-efficient manner. The Z.Sonic turn ...